Introducing Spindle Muscle+
The first daily postbiotic designed
for the gut-muscle connection
Your gut is a communication hub that sends signals throughout your body, including to your muscles. This is known as the gut-muscle connection.
is the first targeted daily postbiotic designed to optimize this communication to help build muscle strength.
Clinically proven muscle strength gain²
Works alongside GLP-1 to help preserve lean muscle mass¹
Restores gut barrier integrity³
Optimizes the gut-muscle connection³
- Kang et al., Nutrients, 2024. Based on a randomized, placebo-controlled 12-week study of Akkermansia MYO™ in adults ages 60+ (mostly women). Mechanism of action and basic science support broader expected benefits. Individual results may vary based on biology, lifestyle, and other individual factors.
- Third-party clinical study, data on file. Based on a randomized, placebo-controlled 12-week study of Akkermansia MYO™ in adults ages 60-80 (mostly women). Mechanism of action and basic science support broader expected benefits. Individual results may vary based on biology, lifestyle, and other individual factors.
- Depommier et al., Nature Medicine, 2019. Based on a 3-month clinical study of pasteurized Akkermansia in overweight or obese adults with insulin resistance and metabolic syndrome. Individual results may vary.
The strength and precision of

Through a complex process of heat-treated pasteurization, Akkermansia MYO™ is optimized to deliver consistent performance from capsule to body to preserves muscle and increases strength
The hidden burden of muscle loss.
Starting around your mid-30s, you begin losing approx 0.5% of muscle tissue per year. By your 80s, you may lose around 20% of the muscle mass you had at your peak. Strength falls far faster than muscle mass — it can decline 2–5× faster than mass. This gap can be a strong predictor of falls & loss of independence.
Gut strong.
Body stronger.
Guided by science.
Meet our expert advisor, Dr. Marcia C. Haigis, Professor of Cell Biology and Co-Director of the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School.
